Adrenomed AG announces publication of Phase II trial design of Adrecizumab to treat septic shock
Adrenomed AG, the vascular integrity company, today announced that the Phase II clinical trial design of AdrenOSS-II was published by the peer-reviewed open access journal BMJ Open. The currently ongoing Phase II trial is conducted to assess the…